RecruitingNCT04437628

Prognostic Value Of Short-Term Follow-up Biomarkers After Discharge In hOspitalized Patients With Acute Heart Failure

Sponsor

Wonju Severance Christian Hospital

Enrollment

1,500 participants

Start Date

Feb 1, 2021

Study Type

OBSERVATIONAL

Conditions

Heart Failure

Summary

Several surrogate biomarkers including natriuretic peptide(NP), and growth differentiation factor-15(GDF-15) and ST2 has prognostic significance in heart failure(HF), and reductions in its value may predict clinical improvement. However, there are limited data regarding the prognostic value of these biomarkers during short-term follow-up after discharge in acute decompensated heart failure. The purpose of this study is to evaluate the prognostic value of short-term follow-up surrogate biomarkers for predicting prognosis of hospitalized patients with acute decompensated heart failure.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether certain blood tests taken shortly after discharge from hospital can predict which heart failure patients are most at risk for complications or readmission. **You may be eligible if...** - You were hospitalized for heart failure with reduced pumping function (ejection fraction below 40%) - You are being discharged from the hospital - You are willing to be contacted by phone for follow-up **You may NOT be eligible if...** - You have a serious illness that is expected to limit your life to less than 3 months - You are unwilling or unable to be reached by telephone for follow-up Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.